Valuation: Illumina, Inc.

Market Cap 28.38B 24.55B 22.93B 21.03B 39.56B 2,701B 40.19B 269B 106B 1,354B 107B 104B 4,476B P/E 2026 *
37.6x
P/E 2027 * 32.2x
Enterprise Value 28.63B 24.76B 23.13B 21.21B 39.9B 2,725B 40.53B 271B 106B 1,366B 108B 105B 4,515B EV / Sales 2026 *
6.19x
EV / Sales 2027 * 5.63x
Free-Float
74.97%
Yield 2026 *
-
Yield 2027 * -
1 day-2.97%
1 week-8.36%
Current month-8.36%
1 month-1.98%
3 months+35.51%
6 months+57.00%
Current year+43.31%
1 week 187.05
Extreme 187.05
207
1 month 178.88
Extreme 178.88
207
Current year 112.65
Extreme 112.65
207
1 year 88
Extreme 88
207
3 years 68.7
Extreme 68.7
207
5 years 68.7
Extreme 68.7
526
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 24/09/2023
Director of Finance/CFO 50 14/04/2024
Chief Tech/Sci/R&D Officer - 31/01/2026
Director TitleAgeSince
Director/Board Member 65 27/07/2016
Director/Board Member 66 31/12/2016
Director/Board Member 65 04/02/2019
Date Insider Type Main position Quantity % Market Cap.
05/08/26
Corvex Management LP
SellCompany -283,269 0.1872%
04/08/26 Other

Director

0 0%
30/07/26 Sell

General Counsel

-615 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-2.97%-8.36%+96.82%+0.40% 28.38B
+2.41%+3.43%+30.62%+7.65% 220B
+2.39%+5.02%+3.16%-19.90% 144B
+1.36%+7.21%-19.37%+22.50% 134B
+0.02%+5.52%-52.11%-2.80% 71.46B
+0.45%+4.24%+15.13%+12.37% 51.71B
+1.05%+7.19%-14.42%-19.02% 50.84B
+3.28%+5.49%+28.07%+15.38% 41.23B
+1.79%+7.83%+46.35%+40.43% 39.95B
-5.06%+0.46%-24.35%+13.54% 30.57B
Average +0.47%+3.66%+10.99%+7.06% 81.15B
Weighted average by Cap. +1.36%+4.51%+7.30%+4.90%

Financials

2026 *2027 *
Net sales 4.62B 4B 3.73B 3.43B 6.44B 440B 6.55B 43.82B 17.2B 221B 17.36B 16.98B 729B 4.91B 4.25B 3.96B 3.64B 6.84B 467B 6.95B 46.52B 18.26B 234B 18.43B 18.03B 774B
Net income 771M 667M 622M 571M 1.07B 73.34B 1.09B 7.3B 2.87B 36.76B 2.89B 2.83B 122B 889M 769M 718M 659M 1.24B 84.65B 1.26B 8.43B 3.31B 42.43B 3.34B 3.27B 140B
Net Debt 246M 213M 199M 182M 343M 23.41B 348M 2.33B 915M 11.74B 924M 904M 38.8B -729M -631M -589M -540M -1.02B -69.38B -1.03B -6.91B -2.71B -34.78B -2.74B -2.68B -115B
Logo Illumina, Inc.
Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.
Employees
8,625
Date Price Change Volume
07/08/26 US$187.96 -2.97% 1,825,159
06/08/26 US$193.72 -3.08% 4,276,169
05/08/26 US$199.87 -1.55% 2,266,096
04/08/26 US$203.01 +2.45% 3,104,446
03/08/26 US$198.16 -3.38% 2,612,022
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
187.96USD
Average target price
195.83USD
Spread / Average Target
+4.19%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock